vs
NBT BANCORP INC（NBTB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是NBT BANCORP INC的1.1倍（$197.9M vs $184.5M），NBT BANCORP INC净利率更高（27.7% vs 6.7%，领先21.0%），过去两年NBT BANCORP INC的营收复合增速更高（14.6% vs 14.4%）
NBT银行是美国的金融机构，旗下设有176个营业网点，分布于纽约、宾夕法尼亚、佛蒙特、马萨诸塞、新罕布什尔、缅因及康涅狄格州。其母公司为NBT Bancorp Inc.，总部位于美国纽约州诺威奇，在纳斯达克全球精选市场上市，股票代码为NBTB。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
NBTB vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$184.5M
净利率更高
NBTB
高出21.0%
6.7%
两年增速更快
NBTB
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $184.5M | $197.9M |
| 净利润 | $51.1M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 27.7% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | 127.2% | 143.9% |
| 每股收益（稀释后） | $0.98 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NBTBRGEN
| Q1 26 | $184.5M | — | ||
| Q4 25 | $185.1M | $197.9M | ||
| Q3 25 | $186.1M | $188.8M | ||
| Q2 25 | $171.2M | $182.4M | ||
| Q1 25 | $154.7M | $169.2M | ||
| Q4 24 | $148.5M | $174.1M | ||
| Q3 24 | $147.4M | $154.9M | ||
| Q2 24 | $140.4M | $154.1M |
净利润NBTBRGEN
| Q1 26 | $51.1M | — | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $54.5M | $14.9M | ||
| Q2 25 | $22.5M | $14.9M | ||
| Q1 25 | $36.7M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $38.1M | $-654.0K | ||
| Q2 24 | $32.7M | $3.3M |
毛利率NBTBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率NBTBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 37.6% | 9.0% | ||
| Q3 25 | 38.6% | 8.9% | ||
| Q2 25 | 17.9% | 7.6% | ||
| Q1 25 | 30.5% | 3.9% | ||
| Q4 24 | 30.7% | -17.7% | ||
| Q3 24 | 33.1% | -5.1% | ||
| Q2 24 | 29.9% | 1.0% |
净利率NBTBRGEN
| Q1 26 | 27.7% | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | 29.3% | 7.9% | ||
| Q2 25 | 13.2% | 8.2% | ||
| Q1 25 | 23.8% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 25.8% | -0.4% | ||
| Q2 24 | 23.3% | 2.2% |
每股收益（稀释后）NBTBRGEN
| Q1 26 | $0.98 | — | ||
| Q4 25 | $1.09 | $0.24 | ||
| Q3 25 | $1.03 | $0.26 | ||
| Q2 25 | $0.44 | $0.26 | ||
| Q1 25 | $0.77 | $0.10 | ||
| Q4 24 | $0.77 | $-0.55 | ||
| Q3 24 | $0.80 | $-0.01 | ||
| Q2 24 | $0.69 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $160.9M | $542.2M |
| 股东权益账面价值 | $1.9B | $2.1B |
| 总资产 | $16.2B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.08× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资NBTBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务NBTBRGEN
| Q1 26 | $160.9M | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NBTBRGEN
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.9B | $2.1B | ||
| Q2 25 | $1.8B | $2.1B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B |
总资产NBTBRGEN
| Q1 26 | $16.2B | — | ||
| Q4 25 | $16.0B | $2.9B | ||
| Q3 25 | $16.1B | $2.9B | ||
| Q2 25 | $16.0B | $2.9B | ||
| Q1 25 | $13.9B | $2.9B | ||
| Q4 24 | $13.8B | $2.8B | ||
| Q3 24 | $13.8B | $2.8B | ||
| Q2 24 | $13.5B | $2.9B |
负债/权益比NBTBRGEN
| Q1 26 | 0.08× | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流NBTBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $235.2M | $25.7M | ||
| Q3 25 | $80.6M | $48.1M | ||
| Q2 25 | $46.5M | $28.6M | ||
| Q1 25 | $42.0M | $15.0M | ||
| Q4 24 | $188.6M | $39.2M | ||
| Q3 24 | $52.1M | $49.3M | ||
| Q2 24 | $50.5M | $42.2M |
自由现金流NBTBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $218.9M | $17.6M | ||
| Q3 25 | $74.3M | $43.4M | ||
| Q2 25 | $44.1M | $21.5M | ||
| Q1 25 | $38.3M | $11.4M | ||
| Q4 24 | $176.8M | $33.6M | ||
| Q3 24 | $47.8M | $42.3M | ||
| Q2 24 | $49.1M | $37.4M |
自由现金流率NBTBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 118.2% | 8.9% | ||
| Q3 25 | 40.0% | 23.0% | ||
| Q2 25 | 25.8% | 11.8% | ||
| Q1 25 | 24.8% | 6.8% | ||
| Q4 24 | 119.0% | 19.3% | ||
| Q3 24 | 32.4% | 27.3% | ||
| Q2 24 | 35.0% | 24.3% |
资本支出强度NBTBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 8.8% | 4.1% | ||
| Q3 25 | 3.4% | 2.5% | ||
| Q2 25 | 1.4% | 3.9% | ||
| Q1 25 | 2.4% | 2.1% | ||
| Q4 24 | 7.9% | 3.2% | ||
| Q3 24 | 2.9% | 4.5% | ||
| Q2 24 | 1.0% | 3.1% |
现金转化率NBTBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.48× | 3.23× | ||
| Q2 25 | 2.06× | 1.92× | ||
| Q1 25 | 1.14× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.54× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NBTB
| Net Interest Income | $134.3M | 73% |
| Noninterest Income | $50.1M | 27% |
RGEN
暂无分部数据
